Floatz logo

FLUDROCORTISONE

Adrenal Insufficiency

Nantes University HospitalSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Adrenal Insufficiency cohort.

Asset / SponsorPhaseRating
Solu-Cortef
Vastra Gotaland Region
Phase 3BB
TETRACOSACTIDE
University of Virginia
Phase 3BB
Metyrapone
Nationwide Children's Hospital
N/AD

Same molecule, other indications

FLUDROCORTISONE is also rated in:

Advanced Metastatic Castration Resistant Prostate CancerDormant
BB
Indicative ·
70 / 100
View asset →
congenital adrenal hyperplasiaDormant
BB
Indicative ·
69 / 100
View asset →
Parkinson diseaseDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →